Sophie Marie Gutenthaler-Tietze

Sophie Marie Gutenthaler-Tietze

Auto-generated profile, based on publicly available information

Sophie Marie Gutenthaler-Tietze

Chair of Bioinorganic Chemistry, Heinrich Heine University of Düsseldorf, Universitätsstr. 1, Düsseldorf, Germany, 40225

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2022 in Inorganic Chemistry Frontiers
Verified
Journal Article
Open access
PDF file
SGSophie M. Gutenthaler
Sophie M. Gutenthaler
Satoru  TsushimaSatoru Tsushima
Satoru Tsushima
RSRobin Steudtner
Robin Steudtner
MGManuel Gailer
Manuel Gailer
AHAnja Hoffmann-Röder
Anja Hoffmann-Röder
LDLena J. Daumann
Lena J. Daumann
Taking a closer look at Lanmodulin’s remarkable selectivity for lanthanides (Ln) over Ca( ii ) and high Ln/actinide affinities on the amino acid level by investigating the four binding-loops as peptides with Ca( ii ), Eu( iii ), Tb( iii ) and Cm( iii ).

30 July 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
AZAlexa M. Zytnick
Alexa M. Zytnick
SGSophie M. Gutenthaler-Tietze
Sophie M. Gutenthaler-Tietze
AAAllegra T. Aron
Allegra T. Aron
ZRZachary L. Reitz
Zachary L. Reitz
MPManh Tri Phi
Manh Tri Phi
NMNorma Cecilia Martinez-Gomez
Norma Cecilia Martinez-Gomez
Many bacteria secrete metallophores, low-molecular-weight organic compounds that bind ions with high selectivity and affinity, in order to access essential metals from the environment. Previous work has elucidated the structures and biosynthetic machinery of metallophores specific for iron, zinc, nickel, molybdenum, and copper. No physiologically relevant lanthanide-binding metallophore has been discovered despite the knowledge that lanthanide metals (Ln) have been revealed to be essential cofactors for certain alcohol dehydrogenases across a diverse range of phyla. Here, we report the biosynthetic machinery, the structure, and the physiological relevance of a lanthanophore, methylolanthanin. The structure of methylolanthanin exhibits a unique 4-hydroxybenzoate moiety which has not previously been described in other metallophores. We find that production of methylolanthanin is required for normal levels of Ln accumulation in the methylotrophic bacteriumMethylobacterium extorquensAM1, while overexpression of the molecule greatly increases bioaccumulation and adsorption. Our results provide a clearer understanding of how Ln-utilizing bacteria sense, scavenge, and store Ln; essential processes in the environment where Ln are poorly bioavailable. More broadly, the identification of this lanthanophore opens doors for study of how biosynthetic gene clusters are repurposed for additional functions and the complex relationship between metal homeostasis and fitness.

18 August 2021 in British Journal of Pharmacology
Verified
Journal Article
Open access
PSPaulina Sander
Paulina Sander
MFMichael Feng
Michael Feng
MSMaria K. Schweitzer
Maria K. Schweitzer
FWFabiola Wilting
Fabiola Wilting
SGSophie M. Gutenthaler
Sophie M. Gutenthaler
Johann SchredelsekerJohann Schredelseker
Johann Schredelseker
Background and Purpose: Treatment of cardiac arrhythmia remains challenging due to severe side effects of common anti‐arrhythmic drugs. We previously demonstrated that mitochondrial Ca2+ uptake in cardiomyocytes represents a promising new candidate structure for safer drug therapy. However, druggable agonists of mitochondrial Ca2+ uptake suitable for preclinical and clinical studies are still missing.Experimental Approach: Herewe screened 727 compounds with a history of use in human clinical trials in a three‐step screening approach. As a primary screening platform we used a permeabilized HeLa cell‐based mitochondrial Ca2+ uptake assay. Hits were validated in cultured HL‐1 cardiomyocytes and finally tested for anti‐arrhythmic efficacy in three translational models: a Ca2+ overload zebrafish model and cardiomyocytes of both a mouse model for catecholaminergic polymorphic ventricular tachycardia (CPVT) and induced pluripotent stem cell derived cardiomyocytes from a CPVT patient.Key Results: We identifiedtwo candidate compounds, the clinically approved drugs ezetimibe and disulfiram, which stimulate SR‐mitochondria Ca2+ transfer at nanomolar concentrations. This is significantly lower compared to the previously described mitochondrial Ca2+ uptake enhancers (MiCUps) efsevin, a gating modifier of the voltage‐dependent anion channel 2, and kaempferol, an agonist of the mitochondrial Ca2+ uniporter. Both substances restored rhythmic cardiac contractions in a zebrafish cardiac arrhythmia model and significantly suppressed arrhythmogenesis in freshly isolated ventricular cardiomyocytes from a CPVT mouse model as well as induced pluripotent stem cell derived cardiomyocytes from a CPVT patient.Conclusion and Implications: Taken together we identified ezetimibe and disulfiram as novel MiCUps and efficient suppressors of arrhythmogenesis and as such as, promising candidates for future preclinical and clinical studies.

21 December 2022 in Chemistry – A European Journal
Verified
Journal Article
Open access
JSJames W. Southwell
James W. Southwell
RHReyme Herman
Reyme Herman
DRDaniel J. Raines
Daniel J. Raines
JCJustin E. Clarke
Justin E. Clarke
IBIsabelle Böswald
Isabelle Böswald
ADAnne‐Kathrin Duhme‐Klair
Anne‐Kathrin Duhme‐Klair
Due to rising resistance, new antibacterial strategies are needed, including methods for targeted antibiotic release. As targeting vectors, chelating molecules called siderophores that are released by bacteria to acquire iron have been investigated for conjugation to antibacterials, leading to the clinically approved drug cefiderocol. The use of small‐molecule catalysts for prodrug activation within cells has shown promise in recent years, and here we investigate siderophore‐linked ruthenium catalysts for the activation of antibacterial prodrugs within cells. Moxifloxacin‐based prodrugs were synthesised, and their catalyst‐mediated activation was demonstrated under anaerobic, biologically relevant conditions. In the absence of catalyst, decreased antibacterial activities were observed compared to moxifloxacin versus Escherichia coli K12 (BW25113). A series of siderophore‐linked ruthenium catalysts were investigated for prodrug activation, all of which displayed a combinative antibacterial effect with the prodrug, whereas a representative example displayed little toxicity against mammalian cell lines. By employing complementary bacterial growth assays, conjugates containing siderophore units based on catechol and azotochelin were found to be most promising for intracellular prodrug activation.

23 September 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
SGSophie M. Gutenthaler‐Tietze
Sophie M. Gutenthaler‐Tietze
JKJerome Kretzschmar
Jerome Kretzschmar
Satoru  TsushimaSatoru Tsushima
Satoru Tsushima
RSRobin Steudtner
Robin Steudtner
BDBjörn Drobot
Björn Drobot
LDLena J. Daumann
Lena J. Daumann
Rare earth elements (REEs) are essential for a clean energy future, high tech, and medicine. For these applications the chemically similar elements need to be tediously separated. Recent discoveries that specific lanthanide‐binding proteins such as lanmodulin (LanM) exist in nature have prompted the development of bio‐inspired separation methods for REEs. Peptides hold great potential for tuning binding sites in various applications as they are easily synthesised, modifiable, and can be immobilised. Here we use the EF‐hand binding site sequences of LanM, the naturally lanthanide‐binding EF‐hand protein from Methylorubrum extorquens AM1, as a blueprint for peptides with potential applications in REE recycling. We show with time‐resolved laser‐induced fluorescence spectroscopy (TRLFS), isothermal titration calorimetry (ITC), and nuclear magnetic resonance (NMR) spectroscopy in combination with molecular dynamics (MD) simulations and circular dichroism (CD) spectroscopy the surprising result that reversing the natural sequence of LanM's metal‐binding loops leads to an increased binding affinity of about one order of magnitude for three out of four natural sequences. Furthermore, we were able to identify structural features responsible for the affinity boost and were able to obtain – only by exchanging one amino acid – a linear uncapped 12‐amino‐acid peptide with a 150 nM affinity for lanthanides.

21 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
SDSophie Dürauer
Sophie Dürauer
HKHyun-Seo Kang
Hyun-Seo Kang
CWChristian Wiebeler
Christian Wiebeler
YMYuka Machida
Yuka Machida
DSDina S. Schnapka
Dina S. Schnapka
JSJulian Stingele
Julian Stingele
The DNA-dependent protease SPRTN maintains genome stability by degrading toxic DNA-protein crosslinks (DPCs). To understand how SPRTN’s promiscuous protease activity is confined to cleavage of crosslinked proteins, we reconstitute the repair of DPCs including their modification with SUMO and ubiquitin chains in vitro. We discover that DPC ubiquitylation strongly activates SPRTN independently of SPRTN’s known ubiquitin-binding domains. Using protein structure prediction, MD simulations and NMR spectroscopy we reveal that ubiquitin binds to SPRTN’s protease domain, promoting an open, active conformation. Replacing key interfacial residues prevents allosteric activation of SPRTN by ubiquitin, leading to genomic instability and cell cycle defects in cells expressing truncated SPRTN variants that cause premature aging and liver cancer in Ruijs-Aalfs syndrome patients. Collectively, our results reveal a ubiquitin-dependent regulatory mechanism that ensures SPRTN activity is deployed precisely when and where it is needed.